HA
Heba T. Abdel‐Mohsen

Publications (3)

Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations
Article scientifique · 2025
Oxindole–benzothiazole hybrids as CDK2 inhibitors and anticancer agents: design, synthesis and biological evaluation
Article scientifique · 2024
Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors
Article scientifique · 2024

Domaines principaux

Sciences de la vie et biotechnologies3

Statistiques

Consultations0
Téléchargements0